Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $0.0044
Latest analyst grade actions
1229 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 59.29 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 39.14 | Oscillator | Neutral |
| Williams %R (14) | -59.09 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.00 (Hist 0.00) | Oscillator | Strong Buy |
| Average Directional Index (14) | 63.89 (+DI 36.2 / -DI 23.3) | Trend | Strong Buy |
| EMA 20 | 0.00 | MA | Strong Buy |
| SMA 20 | 0.00 | MA | Strong Buy |
| EMA 50 | 0.00 | MA | Strong Buy |
| SMA 50 | 0.00 | MA | Strong Buy |
| SMA 200 | 0.00 | MA | Strong Buy |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
SEC EDGAR filings · last 12 months
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — ECGI Holdings Inc. (OTC: ECGI) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork ), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.
Proposed Acquisition Would Mark ECGI's Entry into the $5.3 Trillion U.S. Healthcare Industry with an Experienced Operating Team Across Medicare Advantage, Healthcare Services, Insurance Administration and AI-Enabled Health Technology Proposed Acquisition Would Mark ECGI's Entry into the $5.3 Trillion U.S. Healthcare Industry with an Experienced Operating Team Across Medicare Advantage, Healthcare Services, Insurance Administration and AI-Enabled Health Technology
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Nov 30, 2023 | — | -0.00 | — | — |
TTM vs. 5-year historical average (annual ratios)
| Metric | ECGI | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.6x | -0.8x · sector 20.4x | Discount |
| Forward P/E | — | — | n/a |
| Price / Book | -0.3x | -0.5x | Discount |
| Price / Sales | 0.4x | 36.1x | Discount |
| EV / EBITDA | -208.8x | -1.8x | Elevated |
| Return on equity | 87.0% | — | Top tier |
| Gross margin | -21.8% | -1215.1% | Below hist. |
| Debt / Equity | -0.45 | -0.45 | Conservative |
| Piotroski / Altman Z | 4/9 | Z -9.96 | Distress |
Discounted cash flow model